Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998
Long-Term Follow-up of Pts with SSPE Treated with Intraventricular alpha-Interferon
Neurol 48:526-528, Anlar,B.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Intraventricular Interferon and Oral Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis
Neurol 42:488-491, Yalaz,K.,et al, 1992
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Intrathecally Administered Natural Human Fibroblast Interferon Reduces Exacerbations of Multiple Sclerosis
Arch Neurol 44:589-595, Jacobs,L.,et al, 1987
From the National SSPE Registry
Neurol 37:1883-1884, Dyken,P.R.&Cunningham,S., 1987
A Major Role for Viruses in Acute Childhood Encephalopathy
Lancet 1:989-991, Kennedy,C.R.,et al, 1986
Multicentre Double-Blind Study of Intrathecally Admin Natural Human Fibroblast Interferon on Exacerb of MS
Lancet 2:1411-1413, Jacobs,L.,et al, 1986
Intrathecal Use Of Interferon In Encephalitis
NEJM 305:1283-1284, Prange,H.,et al, 1981
Antiviral Agents, (Second of Two Parts)
NEJM 302:949-953, Hirsch,M.S.,et al, 1980